Aims and Scope of Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Mycobacterial Diseases aims to provide a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections, including (but not limited to) epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance and public policy, and encourages the submission of clinical studies, thematic reviews and case reports. Journal of Clinical Tuberculosis and Mycobacterial Diseases is an Open Access publication. Less
Key Metrics
CiteScore 

2.5
SJR 

Q3Infectious Diseases

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 1860 |
| Publication Time | 30 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Development of a diagnostic nomogram for tuberculous pleural effusion.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
A diagnostic nomogram for tuberculous pleural effusion: Methodological considerations.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Challenges in tuberculosis screening before TNF-α inhibitors: A case report highlighting gaps in current practice.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Development of a diagnostic nomogram for tuberculous pleural effusion.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
A diagnostic nomogram for tuberculous pleural effusion: Methodological considerations.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Challenges in tuberculosis screening before TNF-α inhibitors: A case report highlighting gaps in current practice.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases